Loading…
LENZ Therapeutics, Inc. is projected to decline to $7.37 by 2027, a -5% move from its current price of $7.73. LENZ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.41 | $7.73 | $8.06 | +0.03% |
| May 30 | $7.29 | $7.73 | $8.21 | +0.06% |
| May 31 | $7.19 | $7.74 | $8.32 | +0.09% |
| Jun 1 | $7.12 | $7.74 | $8.42 | +0.12% |
| Jun 2 | $7.05 | $7.74 | $8.50 | +0.15% |
| Jun 3 | $6.99 | $7.74 | $8.58 | +0.17% |
| Jun 4 | $6.93 | $7.75 | $8.65 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.93 | $7.75 | $8.65 | +0.20% |
| Week 2 | $6.63 | $7.76 | $9.08 | +0.41% |
| Week 3 | $6.42 | $7.78 | $9.43 | +0.61% |
| Week 4 | $6.24 | $7.79 | $9.73 | +0.82% |
| Week 5 | $6.09 | $7.81 | $10.01 | +1.02% |
| Week 6 | $5.96 | $7.82 | $10.27 | +1.23% |
| Week 7 | $5.85 | $7.84 | $10.52 | +1.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults.
LENZ Therapeutics was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
LENZ Therapeutics, Inc. trades at $7.55 with a market cap of $236.73M. It is ranked 3723.
The current forecast suggests a near-term Neutral phase in 2026 and 2027, followed by a Bullish trajectory from 2028 onward, with the strongest upside by 2050. The 2026 average is $7.55 and the 2050 forecast shows an average of $29.85, with a max of $68.02 and a min of $13.43. The forecast also shows a long-run bullish sentiment, culminating in a 2050 ROI of 295.4%.
A major floor 39.8% below — a decisive break under it would weaken the trend.
The nearest floor, 14.0% below — buyers have tended to step in here.
The nearest ceiling, 31.7% above — a clean break opens room to run.
A major ceiling 175.2% above — clearing it would confirm fresh momentum.
Key LENZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LENZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.55 | Buy | $7.59 | Buy |
| MA 10 | $7.40 | Buy | $7.72 | Buy |
| MA 20 | $8.33 | Sell | $8.17 | Sell |
| MA 50 | $9.19 | Sell | $9.60 | Sell |
| MA 100 | $12.06 | Sell | $12.88 | Sell |
| MA 200 | $22.60 | Sell | $17.99 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.54 | Neutral |
| Stoch RSI (14) | 51.83 | Neutral |
| CCI (20) | -41.07 | Neutral |
| Williams %R (14) | -68.33 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -23.16 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 31.67 | Neutral |
| TRIX (15) | -0.92 | Sell |
| Awesome (5,34) | -1.32 | Sell |
| Ultimate (7,14,28) | 49.50 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 7.81 | Sell |
| ADX (14) | 21.96 | Sell |
| ATR (14) | 0.34 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 40. The 30-day range runs from $5.64 to $10.11, indicating limited upside within the near term.
Near-term price dynamics show the stock trading below the SMA50 of $9.35 while well below the SMA200 of $22.86. Key support is at $6.65 and resistance at $10.18, framing a tight near-term trading window that could constrain moves until a breakout or breakdown occurs.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.65 | $7.73 | $9.89 | 0% | Neutral | |
| $5.54 | $7.37 | $10.54 | -5% | Neutral | |
| $6.54 | $9.09 | $13.67 | +18% | Neutral | |
| $7.79 | $11.24 | $17.59 | +45% | Bullish | |
| $6.88 | $10.28 | $16.63 | +33% | Bullish | |
| $6.60 | $10.18 | $16.95 | +32% | Bullish | |
| $6.82 | $10.83 | $18.51 | +40% | Bullish | |
| $5.84 | $9.54 | $16.68 | +23% | Bullish | |
| $6.82 | $11.45 | $20.46 | +48% | Bullish | |
| $8.26 | $14.24 | $25.94 | +84% | Bullish | |
| $8.25 | $16.09 | $31.80 | +108% | Bullish | |
| $13.36 | $29.68 | $65.89 | +284% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.65 | $7.73 | $9.10 | +0.00% |
| June 2026 | $6.37 | $7.56 | $9.27 | -2.15% |
| July 2026 | $6.59 | $7.94 | $9.92 | +4.94% |
| August 2026 | $6.76 | $8.23 | $10.44 | +3.65% |
| September 2026 | $6.42 | $7.88 | $10.13 | -4.25% |
| October 2026 | $6.15 | $7.61 | $9.89 | -3.40% |
| November 2026 | $6.21 | $7.73 | $10.15 | +1.58% |
| December 2026 | $5.96 | $7.47 | $9.89 | -3.40% |
Click any year to see its month-by-month LENZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LENZ Therapeutics, Inc.'s 2026 outlook centres on $7.73, within a $6.65 to $9.89 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LENZ could reach as high as $10.54, with a base case around $7.37 and support toward $5.54 — roughly -5% from $7.73. A consolidation phase looks the most probable path here.
Expect LENZ to range from $6.54 to $13.67 through 2028. The $9.09 average target implies a +18% move from current prices. That is up +23% on the projected 2027 average. Price action looks broadly range-bound.
The LENZ price prediction for 2029 points to an average of $11.24 (low $7.79, high $17.59) — a potential gain of +45% on today's $7.73. Buyers look set to stay in control over this stretch.
In 2030, LENZ is projected to trade between $6.88 and $16.63, averaging $10.28 — a potential gain of +33% from today's $7.73. That is -9% versus the projected 2029 average. Momentum favours further upside here.
LENZ Therapeutics, Inc.'s 2031 outlook centres on $10.18, within a $6.60 to $16.95 range. That is -1% versus the projected 2030 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LENZ could reach as high as $18.51, with a base case around $10.83 and support toward $6.82 — roughly +40% from $7.73. Momentum favours further upside here.
Expect LENZ to range from $5.84 to $16.68 through 2033. The $9.54 average target implies a +23% move from current prices. That is -12% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The LENZ price prediction for 2034 points to an average of $11.45 (low $6.82, high $20.46) — a potential gain of +48% on today's $7.73. Momentum favours further upside here.
In 2035, LENZ is projected to trade between $8.26 and $25.94, averaging $14.24 — a potential gain of +84% from today's $7.73. That is up +24% on the projected 2034 average. Buyers look set to stay in control over this stretch.
LENZ Therapeutics, Inc.'s 2040 outlook centres on $16.09, within a $8.25 to $31.80 range. That is up +13% on the projected 2035 average. That marks a +108% change versus current levels. Momentum favours further upside here.
By 2050, LENZ could reach as high as $65.89, with a base case around $29.68 and support toward $13.36 — roughly +284% from $7.73. Buyers look set to stay in control over this stretch.
Investing $1,000 in LENZ today (≈ 129.366106 LENZ) could be worth
$3,839.7
+$2,839.7 (+284%) by 2050 · US Dollar
Based on the average projected LENZ price of $29.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LENZwould be worth at today's price.
$1,000 invested in LENZ on May 27, 2025 (≈ 34.013606 LENZ) would be worth
$262.93
-$737.07 (-73.7%) today · 0.26× · US Dollar
Based on a LENZ entry price of $29.4 vs. today's $7.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.2 | $1,073.61 | +7.4% |
| 1 month ago | $9.76 | $792.01 | -20.8% |
| 3 months ago | $13.52 | $571.75 | -42.8% |
| 6 months ago | $30.52 | $253.28 | -74.7% |
| 1 year ago | $29.4 | $262.93 | -73.7% |
| All time (4.9y) ago | $129.5 | $59.69 | -94.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LENZ forecast.
Our base-case forecast reaches $15.00 around 2040.
Implied market cap at $15.00: $470.32M
The multi-year forecast points to a bullish path after a dip into neutral territory in the mid-2020s. In 2026 the avg price is $7.55 with an ROI of 0 and neutral sentiment; in 2027 the avg price is $7.29 with an ROI of -3.5 and neutral sentiment. From 2028 onward the outlook turns bullish, with 2028 avg $9.19 and ROI 21.8; 2029 avg $11.21 and ROI 48.4; 2030 avg $10.26 and ROI 35.9.
The forecast continues to show growth through 2031 ($10.21, ROI 35.3), 2032 ($10.77, ROI 42.6), and 2033 ($9.49, ROI 25.7). By 2034 the avg rises to $11.65 with ROI 54.4, and 2035 to $14.48 with ROI 91.7. The trajectory accelerates toward 2040, where the avg is $16.55 and ROI reaches 119.2, and culminates in 2050 with an avg of $29.85 and ROI of 295.4.
These figures are estimates and not guarantees, reflecting market conditions and assumptions embedded in the projection.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $10.26, with a min of $6.75 and a max of $16.87, and a forecast ROI of 35.9%. The sentiment is BULLISH.
The forecast indicates Neutral sentiment in 2026 and 2027, then Bullish from 2028 onward with substantial upside by 2050 (avg $29.85; ROI 295.4). Near-term years include a slight negative in 2027 (ROI -3.5%). These are estimates, not guarantees.
The 2040 forecast shows a max of $33.46 and an avg of $16.55, with a 2040 ROI of 119.2. The 2050 max is $68.02, indicating higher potential later, but the 2040 midpoint is below $30.
The current price is $7.55.
For 2050 the forecast shows a min of $13.43, an avg of $29.85, and a max of $68.02, with a ROI of 295.4 and sentiment BULLISH.
LENZ Therapeutics, Inc. Community Discussion
0Share your LENZ Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.